ClinicalTrials.gg

Program

ENV-294

A development code. Also written as “ENV-294 Capsule”.

Its studies are mostly in Dermatitis, Atopic · Asthma, led by Enveda Therapeutics.

Furthest: phase 2, since Dec 10, 20254 company-led studies, 3 open or runningNext primary completion: Dec 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Enveda Therapeutics43 open or runningphase 2since Dec 10, 2025Sep 20, 2025Dec 2026phase 2 · NCT07298395

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 20, 2025First study: phase 1 study in Dermatitis, AtopicFirst studyNCT07336940 · 9 enrolled · United States
  2. Dec 10, 20252 phase 2 studiesPhase 2 reachedNCT07301255, NCT07298395
  3. Jun 7, 2026Phase 2 study in Dermatitis, AtopicNCT07643766 · 200 planned · United States

Ahead

  1. Dec 2026Primary completion: phase 2 study in AsthmaNCT07301255
  2. Dec 2026Primary completion: phase 2 study in Dermatitis, AtopicNCT07298395
  3. Dec 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07643766

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07643766Dermatitis, Atopic · United States2RecruitingDec 2027200
NCT07301255Asthma · United States2RecruitingDec 202650
NCT07298395Dermatitis, Atopic · United States2RecruitingDec 2026105
NCT07336940Dermatitis, Atopic · United States1CompletedJan 13, 20269

How it is read

Names in the registry

  • “ENV-294”, 3 entries
  • “ENV-294 Capsule”, 1 entry

Codes read as this program: ENV294.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.